How big is the MEA Self-monitoring Blood Glucose Devices Market?

The MEA Self-monitoring Blood Glucose Devices Market size is expected to reach USD 253.12 million in 2024 and grow at a CAGR of 5.79% to reach USD 335.39 million by 2029. Read More

What is the current MEA Self-monitoring Blood Glucose Devices Market size?

In 2024, the MEA Self-monitoring Blood Glucose Devices Market size is expected to reach USD 253.12 million. Read More

Who are the key players in MEA Self-monitoring Blood Glucose Devices Market?

Platinum Equity (LifeScan), Abbott Diabetes Care, Ascensia Diabetes Care, ARKRAY Inc. and Roche Diabetes Care are the major companies operating in the MEA Self-monitoring Blood Glucose Devices Market. Read More

What years does this MEA Self-monitoring Blood Glucose Devices Market cover, and what was the market size in 2023?

In 2023, the MEA Self-monitoring Blood Glucose Devices Market size was estimated at USD 238.46 million. The report covers the MEA Self-monitoring Blood Glucose Devices Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the MEA Self-monitoring Blood Glucose Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

MEA Self-monitoring Blood Glucose Devices Companies

This report lists the top MEA Self-monitoring Blood Glucose Devices companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the MEA Self-monitoring Blood Glucose Devices industry.